# Efficacy & Safety of Single Dose Alprostadil Cream (2 Concentrations Enhancer) to Vehicle in Men w/Erectile Dysfunction

> **NCT01810575** · PHASE2 · TERMINATED · sponsor: **Warner Chilcott** · enrollment: 16 (actual)

## Conditions studied

- Erectile Dysfunction

## Interventions

- **DRUG:** WC3036-11F/Alprostadil in Vehicle 2.5%
- **DRUG:** WC3036-12F/Alprostadil in Vehicle 0.5%
- **DRUG:** WC3036-13P/Vehicle Only 0.5%

## Key facts

- **NCT ID:** NCT01810575
- **Lead sponsor:** Warner Chilcott
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-02
- **Primary completion:** 2013-04
- **Final completion:** 2013-04
- **Target enrollment:** 16 (ACTUAL)
- **Why stopped:** Re-assessment of study
- **Last updated:** 2014-08-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01810575

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01810575, "Efficacy & Safety of Single Dose Alprostadil Cream (2 Concentrations Enhancer) to Vehicle in Men w/Erectile Dysfunction". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01810575. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*